Finasteride, lipophilic 5-α reductase inhibitor was selected as a model drug to evaluate in vivo iontophoretic transdermal delivery of novel lipid-based vesicular carriers (invasomes). The study included three protocols. The protocol I involved formulation of invasomes with terpenes (limonene, carvo...
No comments yet
Be the first to share your thoughts!